Comparison of trimethoprim-sulfamethoxazole and aerosolized pentamidine for primary prophylaxis of Pneumocystis jiroveci pneumonia in immunocompromised patients with connective tissue disease

Rheumatology International

Volumn 28, Issue 7, 2008, Pages 673-676

  Kimura, Miho ^a   Tanaka, Sumiaki ^a   Ishikawa, Akira ^a   Endo, Hirahito ^a   Hirohata, Shunsei ^a   Kondo, Hirobumi ^b  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KITASATO UNIVERSITY MEDICAL CENTER   (Japan)

Author keywords

Pentamidine aerosol; Pneumocystis jiroveci pneumonia; Trimethoprim sulfamethoxazole

Indexed keywords

AZATHIOPRINE; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; METHOTREXATE; MIZORIBINE; PENTAMIDINE; PREDNISOLONE;

ADULT; AGED; ARTICLE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; IMMUNOCOMPROMISED PATIENT; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE COUNT; MALE; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL;

ADULT; AEROSOLS; AGED; CD4 LYMPHOCYTE COUNT; CONNECTIVE TISSUE DISEASES; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MIDDLE AGED; PENTAMIDINE; PNEUMONIA, PNEUMOCYSTIS; RETROSPECTIVE STUDIES; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 41849112378     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-007-0505-4     Document Type: Article

References (7)

1. Hardy WD, Feinberg J, Finkelstein DM, Power ME, He W, Kaczka C, Frame PT, Holmes M, Waskin H, Fass RJ (1992) A controlled trial of trimethoprim- sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 021. N Engl J Med 327:1842-1848
2. Schneider MM, Hoepelman AI, Eeftinck Schattenkerk JK, Nielsen TL, van der Graaf Y, Frissen JP, van der Ende IM, Kolsters AF, Borleffs JC (1992) A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. The Dutch AIDS Treatment Group. N Engl J Med 327:1836-1841
3. Sato T, Inokuma S, Maezawa R, Nakayama H, Hamasaki K, Miwa Y, Okazaki Y, Yamashita M, Tanaka Y, Kono H (2005) Clinical characteristics of Pneumocystis carinii pneumonia in patients with connective tissue diseases. Mod Rheumatol 15:191-7
4. Li J, Huang XM, Fang WG, Zeng XJ (2006) Pneumocystis carinii pneumonia in patients with connective tissue disease. J Clin Rheumatol 12:114-117
5. Ward MM, Donald F (1999) Pneumocystis carinii pneumonia in patients with connective tissue diseases: the role of hospital experience in diagnosis and mortality. Arthritis Rheum 42:780-789
6. Okada J, Kadoya A, Rana M, Ishikawa A, Iikuni Y, Kondo H (1999) Efficacy of sulfamethoxazole-trimethoprim administration in the prevention of Pneumocystis carinii pneumonia in patients with connective tissue disease. Kansenshogaku Zasshi 73:1123-1129
7. Yasuoka A, Tachikawa N, Shimada K, Kimura S, Oka S (1996) (1→3) β-d-Glucan as a quantative serological marker for Pneumocystis carinii pneumonia. Clin Diagn Lab 3:197-199